Publication - Advice and guidance

Coronavirus (COVID-19) mRNA vaccine BNT162b2 Pfizer/BioNTech vaccine: national protocol v2.4

This protocol is for the supply and administration of COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech to individuals in accordance with the national COVID-19 vaccination programme. This protocol only allows administration during or in anticipation of COVID-19 pandemic.

Coronavirus (COVID-19) mRNA vaccine BNT162b2 Pfizer/BioNTech vaccine: national protocol v2.4
COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTechVaccine National Protocol